chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She had an arrhythmia; got really hot all the way down her body; hands were sweaty and clammy; hands were sweaty and clammy; fast heart beat; Dry mouth; She didn't feel good at all; arm soreness; felt like she had a big hot flash; This is a spontaneous report from a contactable consumer (patient).  A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 10Apr2021 at 13:50 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. No other vaccines were given within 4 weeks. The patient medical history was not reported. There were no concomitant medications.  The patient previously took sucrose and experienced drug hypersensitivity, flu vaccine for influenza  immunization (never had a reaction after having a flu vaccine/'I am not allergic to eggs), tetanus vaccine for immunization (The last one she had was 10 or more years ago)  and experienced soreness. On 10Apr2021, The patient experienced  arrhythmia,  got really hot all the way down her body, hands were sweaty and clammy, fast heart beat, dry mouth,  she didn't feel good at all, arm soreness, felt like she had a big hot flash. The patient underwent lab tests and procedures which included heart rate: fast on 10Apr2021. The clinical course is as follows. Within the first 5 minutes of receiving the vaccine she got really hot all the way down her body. Her hands were hands sweaty and clammy. arm soreness. She had an arrhythmia, her heart was pounding fast. She belly breathed and kept calm. She didn't feel good at all. This all lasted for about 5 minutes. She has a pretty good immune system. She was not nervous about getting the vaccine. She had childhood vaccinations and had no problems. She was not nauseated. She just felt like she had a big hot flash through her body. Her mouth was dry. The adverse events did not require a visit to the physician office or emergency room.  The clinical outcome of the events got really hot all the way down her body, hand were sweaty and clammy, fast heart beat,  didn't feel good at all, Dry mouth  was recovered on 10Apr2021 while arm soreness was recovered on 13Apr2021 and while arrhythmia, felt like a big hot flush was unknown.   Information on the lot/batch number has been requested.
16JUN94 pt recvd vax & 23JUN94 began to fell ill-GI cramping & muscle aching persisted 2 wks; 5JUL94 throat swollen & painful & neck stiff; still minor joint & abdo pain
Approximately 15 min. post rabies vaccine, pt. developed headache, ataxia, nausea and vomited x1. Vaccine administered in outpatient clinic and pt. brought to the ER for further evaluation. PO TYLENOL and ZOFRAN given in ER.
5/23/11 mom called to report redness & warm to touch Rt thigh. Seen in clinic & Rt thigh erythema, warm to touch. Pt reports "itchy" erythema injection site measuring 13 cm x 26 cm.
I was getting cold chills, hot flashes, weakness, I wasn't feeling good, it wasn't like when my normal allergies act up. A guest of ours called to let us know that he had tested to let us know that he had tested positive for COVID-19. My wife and I took a home COVID-19 test that came back positive. We called our primary care physician to discuss our positive test and symptoms. He prescribed an antibiotic Azithromycin, three days into the medication neither my wife nor myself were not feeling better. I called my doctor back, he then prescribed Cefdinir, I am halfway through this medication, and I am feeling so much better. I actually feeling like eating now.
The patient was accidentally administered another dose of Vaxelis and Rotateq; inappropriate schedule of drug administration; This non-serious spontaneous safety report, with Case ID: 02387773 (Interaction number 02387767), was received by partner, on 11-MAY-2023 and forwarded to agency on 12-MAY-2023 from other health professional.  The causal relationship between Vaxelis and the reported events "The patient was accidentally administered another dose of Vaxelis and Rotateq and Inappropriate schedule of drug administration" was assessed as not applicable due to the nature of the events.  Further information is expected.
Was sick day after 2nd vaccine for about 24 hours (regular, to be expected).  Then had appendicitis 42 days later and ended up with appendectomy the next day
2 inch diameter raised rash on left thigh.  Itchiness, discomfort, redness visible, afebrile.  Came into office on 1/10/08 to show leg and irritation prominent.
pt recv vax 24JAN97 reporting pt had red cluster type rash w/water blisters w/in rash;rash started this MA;pt has fever but mom does not know how much;instructed to call MD which mom did do;told to bring pt in but rash gone when arriv
Mom contacted office stating that her son had a local reaction from his vaccinations on 9/22/2006.  She stated that her son's right thigh was red and swollen when he woke up in the morning.  Mom stated that the child has no fever at this time.  The child's mother was encouraged to give him Motrin for swelling.  Will follow up in 3 days
This case was reported by a other health professional via call center representative and described the occurrence of white blood cell count increased in a adult patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included chronic lymphocytic leukemia. On 1st April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced white blood cell count increased. On an unknown date, the outcome of the white blood cell count increased was unknown. It was unknown if the reporter considered the white blood cell count increased to be related to SHINGRIX. Additional details were provided as follows: This case was reported by Hospital administration. The age at vaccination was not reported. The hospital administrator stated on online chat that, could SHINGRIX cause an increase in white blood count. The patient with chronic lymphocytic leukaemia and not sure increase was due to chronic lymphocytic leukaemia or shot of SHINGRIX. The hospital administrator closed online chat before any contact information or any other information was obtained.
It probably is my thyroid, I have hypothyroidism, which is an autoimmune disorder, they are still trying to figure it out. My thyroid went really high. High thyroid can cause heart problems, fatigue, all that kind of things. They are trying to lower my medications. On 06/17/2021 I went to the doctor. They did blood work, CAT scan, heart normal, Covid test. I had to be hospitalized for 3 days and 2 nights at medical center because I had chest pain and shortness of breath and heart palpitations.  While at the hospital they gave me nitroglycerin for the chest pain and Zofran for the nausea.
Employee tested every other day d/t spouse/child being positive for Covid. Today's test was positive, employee sent home to quarantine.
Case number PHHY2011US69684 is an initial spontaneous report received from a nurse on 26 Jul 2011. This report refers to an adult male patient. He was given only the CYW-135 liquid component MENVEO (batch number 100053) intramuscularly on 20 Jul 2011. He was vaccinated with a complete reconstituted dose of MENVEO (batch number: 100053) on 21 Jul 2011 which was well tolerated. No other adverse reaction was reported.
pt should have gotten 0.5ml dose for 1st shot, but instead received the 0.25ml
This is a spontaneous report from a contactable consumer (patient's sibling). A currently 65-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date in Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first Pfizer COVID 19 Vaccine about 6-7 weeks ago (in Mar2021). She has partial kidney function along with diabetes (unspecified onset dates). Two days after the vaccine (in Mar2021) she had an excruciating headache. The following day (in Mar2021), she experienced chills, fever and diarrhea. After several weeks (an unspecified date in 2021), she developed shingles. The clinical outcome of the event "shingles" was not resolved while the outcome of events "partial kidney function along with diabetes", excruciating headache, chills, fever and diarrhea was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021476991 same patient, different dose number and event
This spontaneous report as received from a pharmacist refers to a 52 year old male patient. There was no pertinent medical history and drug reactions/allergies. On 01-JUL-2017 the patient was vaccinated with ZOSTAVAX (lot # M034765, Expiration Date 26-OCT-2017) subcutaneous in his left arm for prophylaxis. Concomitant therapies included FLOMAX, prednisolone (manufacture unknown) and gatifloxacin. On an unknown date in July 2017, the patient experienced soreness at the injection site further described as pain when he lift his arm which was ongoing. Pharmacist denied any redness, swelling or rash. No treatment was given. No lab diagnostics/studies was performed. The patient did not seek medical attention. The causality was not provided.
Patient admitted 01/13/22 and tested + for covid.  Expired 02/03/2022 .  Had complicated course, developed acute tubular necrosis, required feeding tube.  Developed covid pneumonia.
6 hours after injection: chills.  12 hours after injection: shivering and fever (101.9 by ear), headache, upset stomach, pain like a sunburn around the face, neck, shoulders.  20 hours after injection:  pain subsides.  23 hours after injection:  fever subsides.  24 hours after injection:  headache subsides
Information has been received from a physician concerning a 19 year old female patient who in approximately August 2006, was vaccinated with a dose of HPV rLi 6 11 16 18 VLP vaccine (yeast).  Subsequently,the patient experienced pain in joints and developed low grade fever.  Unspecified medical attention was sought.  The physician reported that the patient was recovered from her symptoms and stated "all it was was a one day flu. Additional information is expected.
Severe chills lasting Eight hours and fever of 100.1-101.9 lasting 36 hours.
A subtle swelling in the RT lower deltoid area w/ 2 small ecchymosis areas. He doesn't seem to be bothered while I palpate the area and  is active and playful in the exam room. Shoulder and elbow FROM. Pulses nl. Area feels slightly warm .
Patient recieved first vaccine 4/26/2021, reports she had no issues after this dose  Patient recieved second vaccine 6/3/2021, and reports on 6/4/2021 she had heavy bleeding for 7 days. Bleeding spontaneously resolved.
First night had over 101 fever and rigors. Had trouble walking from bed to bath.   Next morning I woke up with a slight rash and ulcers in the female area.   Second morning I woke with my whole body turned red and itchy. Was told by my dr to have it treated at (urgent) care. Was given a steroid shot to be followed up with a Medrol dose pack. So far reroof shot has done nothing to ease the red toe itching.
Day after injection pt c/o fatigue, fever, chills, swelling at site of injection and pain. No redness. Pt states she felt much better next day. Never had reaction before to plain TD.
My arm started to itch within 1/2 hour. The site became hot and red within 5 hours. The redness and swelling was the size of the palm of my hand withing 8 hours. Site is red, hot, and itchy and swollen.  I have taken loratadine which doesn't seem to help much. I've put ice on the site which gave temporary relief.  On day 3 (today) swelling is slightly down but site remains hot and itchy and area of reaction is same size.
Fever, chills, flu-like symptoms, body aches for several days.  About a week or so later, developed a swollen rash on arm where I received the injection. It was swollen, red, itching and hot to the touch.
Resulting in some of the vaccine running down his arm; The vaccine "burned"; Estimated that "2/3" of the vaccine was administered to the patient; This is a spontaneous report received from a non-contactable reporter(s) (Consumer) from medical information team.  A 57-year-old male patient received pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ACCIDENTAL EXPOSURE TO PRODUCT (non-serious), outcome "unknown", described as "Resulting in some of the vaccine running down his arm"; BURNING SENSATION (non-serious), outcome "unknown", described as "The vaccine "burned""; UNDERDOSE (non-serious), outcome "unknown", described as "Estimated that "2/3" of the vaccine was administered to the patient". It was reported that while receiving the vaccine, the patient jerked his arm and the needle came out, resulting in some of the vaccine running down his arm. He stated that the vaccine "burned" thus he moved as he did during administration. It was reported that the clinical staff member who administered the vaccine estimated that "2/3" of the vaccine was administered to the patient. They would like to know if the amount that was administered is sufficient or if they should get more.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
INJECTION SITE WAS REALLY RED FOR 1 DAY, ABOUT 4 - 5 INCH IN LENGTH
pt recv vax 1JUL96 & 2nd dose 15AUG96 & lab eval revealed inc SGOT of 60 on 16AUG96 & 48 on 6SE96; by 11SEP AST 35 and pat recovered;
CONGESTION     POST NASAL DRIP       SEVERE ACHES         CHILLS             FEVER HIGH AS 103.7      BODY ACHES
Ran fever up too 101.8 for two days.  Along with body aches & pains.  Had to take Tylenol every 4-6 hours
Information has been received from a registered nurse concerning a 57 year old male with asthma, hyperlipidaemia and pulmonary hypertension and a history of nasal polyps and dislocated shoulder who on 12-SEP-2007 was vaccinated with a dose of Pneumovax 23 (lot #657143/0380U), IM in the right deltoid. Concomitant therapy included DTaP, prednisone, omalizumab (XOLAIR), mometasone furoate (ASNANEX), atorvastatin calcium (LIPITOR) and albuterol. On 13-SEP-2007, the patient developed a cellulitis at the injection site. The patient returned to the physician's office on 13-SEP-2007 with cellulitis in the injection site arm. The cellulitis was described as painful, red and warm. The elbow was inflamed and the arm was swollen distal to the injection site. Unspecified medical attention was sought. At the time of reporting, the patient was recovering from the events. Cellulitis at injection site, elbow inflamed and arm swollen distal to injection site were considered to be disabling and an other important medical event. Additional information has been requested.
Disruption in menstrual cycle. 20 day cycle followed by 40 day cycle with abnormal non-menstrual bleeding in between cycles. Disruption with extreme fluctuations and irregular bleeding lasted six months.
Patient requested a Moderna booster. The bivalent vaccine was not yet approved, so we administered the original Moderna.
A report from a literature source via MedImmune concerns a 4 year old male. The authors present a rare case of brachial neuritis (Parsonage Turner Syndrome) following intranasal influenza vaccination. The patient was a 4 year old right handed previously healthy boy who presented for evaluation of right upper arm hemi-sensory paresis. Six months prior to the evaluation, the patient had received the FLUMIST vaccination. Two days after the vaccination, the patient experienced constitutional symptoms with low grade fever and at the same time the patient began experiencing sharp pain in the right arm. There was no rash and the patient had not experienced any trauma related injury. The pain improved with symptomatic management over 1-2 months but the patient had continued right proximal arm weakness in elbow flexion and shoulder abduction. MRI imaging of his right upper arm was nonrevealing. Serum laboratory screening evaluation was also negative for infectious and inflammatory etiologies. Electro-diagnostic studies obtained at seven months revealed chronic denervation and re-innervation in the C5-C6 innervated muscles. The outcome of the event of Brachial Neuritis was recovering. The reporter considered Brachial Neuritis serious as an important medical event.
Severe fatigue, headache chills abdominal pain muscle aches. Resolved by 24 hours  after shot
Stunned; Very high fever; Not able to walk; Not able to speak; A spontaneous report was received from a consumer concerning a 74 year old, female patient who experienced very high fever-104.2°F (pyrexia), was stunned (altered state of consciousness), not able to walk (gait inability), and not able to speak (speech disorder). The patient's medical history was not provided. No relevant concomitant medications were reported.  On 10 Mar 2021 at 19:00, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (lot: 029A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 11-Mar-2021, the patient woke up with a very high fever of 104.2°F, stunned, not able to speak or move. The patient took Ibuprofen 600 mg to treat the fever and felt better, but was told that might have been counterproductive.  Treatment details included Ibuprofen 600 mg.  Action taken with mRNA-1273 in response to the events was not reported.   The events of very high fever-104.2°F (pyrexia), was stunned (altered state of consciousness), not able to walk (gait inability), and not able to speak (speech disorder) were considered recovering.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (the event she had symptoms after booster dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (the event she had symptoms after booster dose). At the time of the report, VACCINATION COMPLICATION (the event she had symptoms after booster dose) outcome was unknown. No concomitant medication information was provided. No treatment medication information was given. This case was linked to MOD-2021-389233 (Patient Link).
recurring rash (purpura) of extremities & abd lasting 10-14 days;sx recur intermittently;dx of leukocytoclastic vasculitis;
Shingles right arm 2 days after COVID 19 vaccination.  Evaluated 12/21 and prescribed topical acyclovir and oral vatrex 1g TID x 7 days.  Labs obtained and pending (CMP, CMP, ESR, CRP, Zoster IgG,M, viral swab)
Patient had small rash that went away at injection site-when she returned 10/4/16 the rash was back and large-she said arm was very sore and sensitive-saw pcp who circled the rash and told her to watch for it to increase in size-spoke with pt again on evening of 10/4-said it was very sore still but site had not become any larger.
PATIENT RECEIVED FLU VACCINES. SHE HAD BRUISES, REDNESS AND SWELLING AROUND INJECTION SITE. ACCORDING TO PATIENT SHE HAD WARM SKIN AROUND INJECTION SITE. SHE WENT TO CLINIC AND DOCTOR DIAGNOSED HER WITH CELLULITIS.
Pt received flu-seasonal injection, H1N1 mist, PPV-23 inj on 11-12-09. Our office saw pt 11-13-09- 5x4cm redness (R) bicep, fever 101.7 11-12-09 per mom, T-100.3 on 11-13-c/o weakness.
pain in chest area left side above the heart area; mostly hurts when inhale and exhale; Stress; pain in back around kidney area; Stress; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain in chest area left side above the heart area), PAINFUL RESPIRATION (mostly hurts when inhale and exhale), the first episode of STRESS (Stress), BACK PAIN (pain in back around kidney area) and the second episode of STRESS (Stress) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Psoriatic arthritis and Rheumatoid arthritis.    The patient's past medical history included Allergic rash. Previously administered products included for Drug use for unknown indication: VICODIN and MORPHINE. Past adverse reactions to the above products included Allergic rash with MORPHINE; and Drug allergy with VICODIN. Concurrent medical conditions included Penicillin allergy (penicillin allergy manifested by rash), Drug allergy (morphine allergy manifested by rash) and Drug allergy.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Sep-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced CHEST PAIN (pain in chest area left side above the heart area), PAINFUL RESPIRATION (mostly hurts when inhale and exhale), the first episode of STRESS (Stress), BACK PAIN (pain in back around kidney area) and the second episode of STRESS (Stress). At the time of the report, CHEST PAIN (pain in chest area left side above the heart area) had not resolved, PAINFUL RESPIRATION (mostly hurts when inhale and exhale) outcome was unknown, BACK PAIN (pain in back around kidney area) was resolving and last episode of STRESS (Stress) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: Normal. On an unknown date, Full blood count: Normal. On an unknown date, Red blood cell sedimentation rate: Normal.         Concomitant medication was not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Treatment drug was not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 01-Dec-2021: Medical history and past drug were added. Laboratory data were added. Outcome updated for Chest pain.
Body aches, chills, fever, vomiting, arm and armpit pain, swollen lymph nodes of the left underarm, right eye swelling, rash in bilateral calves
Reporter mentioned that her son diagnosed with COVID19 virus; This is a spontaneous report from Pfizer-sponsored program Covax Support. A contactable consumer (mother) reported for her son (patient) stating that: A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The reporter stated that her son got the first dose of the vaccine and then the next day, he got sick. She mentioned that her son diagnosed with COVID19 virus and already had it for 6 or 7 days now. She was asking if her son needs to get the 2nd dose or if they should reschedule or cancel it. The seriousness of the event COVID-19 was considered as medically significant. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Intussusception Thursday 1:30AM -> 10-7-10 reduced by Barium Enema.